Cost-effectiveness of annual versus biennial screening mammography for women with high mammographic breast density

Journal of Medical Screening

Volumn 21, Issue 4, 2014, Pages 180-188

  Pataky, Reka ^a,b   Ismail, Zahra ^a   Coldman, Andrew J ^b   Elwood, Mark ^c   Gelmon, Karen ^b,d   Hedden, Lindsay ^d,e   Hislop, Greg ^b   Kan, Lisa ^f   McCoy, Bonnie ^d   Olivotto, Ivo A ^g   Peacock, Stuart ^a,b,d  

^a Canadian Centre for Applied Research in Cancer Control   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e Canadian Nurses Association   (Canada)

^f Screening Mammography Program of British Columbia   (Canada)

^g UNIVERSITY OF CALGARY   (Canada)

Author keywords

Breast density; Cost effectiveness; Health economics; Screening mammography

Indexed keywords

ANATOMY AND HISTOLOGY; BREAST; BREAST NEOPLASMS; CANADA; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; EARLY DIAGNOSIS; ECONOMICS; FEMALE; HUMAN; MAMMOGRAPHY; MIDDLE AGED; PROBABILITY; PROCEDURES; RISK; SENSITIVITY AND SPECIFICITY;

BREAST; BREAST NEOPLASMS; BRITISH COLUMBIA; CANADA; COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAMMOGRAPHY; MARKOV CHAINS; MIDDLE AGED; RISK; SENSITIVITY AND SPECIFICITY;

EID: 84927591176     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1177/0969141314549758     Document Type: Article

References (46)

1. Barlow WE, White E, Ballard-Barbash R, et al. Prospective Breast Cancer Risk Prediction Model for Women Undergoing Screening Mammography. Journal of the National Cancer Institute 2006;98:1204-14.
2. Tice JA, Cummings SR, Smith-Bindman R, Ichikawa L, Barlow WE, Kerlikowske K. Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Annals of Internal Medicine 2008;148:337-47.
3. Mandelson MT, Oestreicher N, Porter PL, et al. Breast Density as a Predictor of Mammographic Detection: Comparison of Interval- and Screen-Detected Cancers. Journal of the National Cancer Institute 2000;92:1081-7.
4. McCormack VA, dos Santos Silva I. Breast Density and Parenchymal Patterns as Markers of Breast Cancer Risk: A Meta-analysis. Cancer Epidemiology Biomarkers & Prevention 2006;15:1159-69.
5. Boyd NF, Byng JW, Jong RA, et al. Quantitative Classification of Mammographic Densities and Breast Cancer Risk: Results From the Canadian National Breast Screening Study. Journal of the National Cancer Institute 1995;87:670-5.
6. Boyd NF, Guo H, Martin LJ, et al. Mammographic Density and the Risk and Detection of Breast Cancer. New England Journal of Medicine 2007;356:227-36.
7. van Gils C, Otten JM, Verbeek AM, Hendriks JCL. Mammographic breast density and risk of breast cancer: Masking bias or causality? Eur J Epidemiol 1998;14:315-20.
8. Carney PA, Miglioretti DL, Yankaskas BC, et al. Individual and Combined Effects of Age, Breast Density, and Hormone Replacement Therapy Use on the Accuracy of Screening Mammography. Annals of Internal Medicine 2003;138:168-75.
9. Chiu SY-H, Duffy S, Yen AM-F, Tabár L, Smith RA, Chen H-H. Effect of Baseline Breast Density on Breast Cancer Incidence, Stage, Mortality, and Screening Parameters: 25-Year Follow-up of a Swedish Mammographic Screening. Cancer Epidemiology Biomarkers & Prevention 2010;19:1219-28.
10. Ciatto S, Visioli C, Paci E, Zappa M. Breast density as a determinant of interval cancer at mammographic screening. Br J Cancer 2004;90:393-6.
11. Eriksson L, Czene K, Rosenberg L, Tornberg S, Humphreys K, Hall P. Mammographic density and survival in interval breast cancers. Breast Cancer Research 2013;15:R48.
12. Shen Y, Yang Y, Inoue LYT, Munsell MF, Miller AB, Berry DA. Role of Detection Method in Predicting Breast Cancer Survival: Analysis of Randomized Screening Trials. Journal of the National Cancer Institute 2005;97:1195-203.
13. Aiello EJ, Buist DSM, White E, Porter PL. Association between Mammographic Breast Density and Breast Cancer Tumor Characteristics. Cancer Epidemiology Biomarkers & Prevention 2005;14:662-8.
14. Roubidoux MA, Bailey JE, Wray LA, Helvie MA. Invasive Cancers Detected after Breast Cancer Screening Yielded a Negative Result: Relationship of Mammographic Density to Tumor Prognostic Factors1. Radiology 2004;230:42-8.
15. Porter GJR, Evans AJ, Cornford EJ, et al. Influence of Mammographic Parenchymal Pattern in Screening- Detected and Interval Invasive Breast Cancers on Pathologic Features, Mammographic Features, and Patient Survival. American Journal of Roentgenology 2007;188:676-83.
16. Eriksson L, Czene K, Rosenberg L, Humphreys K, Hall P. The influence of mammographic density on breast tumor characteristics. Breast Cancer Research and Treatment 2012;134:859-66.
17. Gierach GL, Ichikawa L, Kerlikowske K, et al. Relationship Between Mammographic Density and Breast Cancer Death in the Breast Cancer Surveillance Consortium. Journal of the National Cancer Institute 2012;104:1218-27.
18. Olsen AH, Bihrmann K, Jensen MB, Vejborg I, Lynge E. Breast density and outcome of mammography screening: a cohort study. Br J Cancer 2009;100:1205-8.
19. van Gils CH, Otten JDM, Hendriks JHCL, Holland R, Straatman H, Verbeek ALM. High mammographic breast density and its implications for the early detection of breast cancer. J Med Screen 1999;6:200-4.
20. White E, Miglioretti DL, Yankaskas BC, et al. Biennial Versus Annual Mammography and the Risk of Late-Stage Breast Cancer. Journal of the National Cancer Institute 2004;96:1832-9.
21. Moss S. Overdiagnosis and overtreatment of breast cancer: Overdiagnosis in randomised controlled trials of breast cancer screening. Breast Cancer Research 2005;7:230-4.
22. Schousboe JT, Kerlikowske K, Loh A, Cummings SR. Personalizing Mammography by Breast Density and Other Risk Factors for Breast Cancer: Analysis of Health Benefits and Cost-Effectiveness. Annals of Internal Medicine 2011;155:10-20.
23. BC Cancer Agency. Breast Screening Policy.
24. Life Tables, Canada, Provinces and Territories, 2005 to 2007. No. 001 ed.: Statistics Canada, 2012.
25. Bonomi AE, Boudreau DM, Fishman PA, et al. Quality of life valuations of mammography screening. Quality of Life Research 2008;17:801-14.
26. Schleinitz MD, DePalo D, Blume J, Stein M. Can differences in breast cancer utilities explain disparities in breast cancer care? J Gen Intern Med 2006;21:1253-60.
27. Earle CC, Chapman RH, Baker CS, et al. Systematic overview of cost-utility assessments in oncology. J Clin Oncol 2000;18:3302-17.
28. Torrance GW, Feeny DH, Furlong WJ, Barr RD, Zhang YM, Wang QN. Multiattribute utility function for a comprehensive health status classification system - Health Utilities Index Mark 2. Med Care 1996;34:702-22.
29. Screening Mammography Program: 2010 Annual Report. Vancouver, BC: BC Cancer Agency, 2010.
30. BC Medical Services Commission. Payment Schedule. Ministry of Health Services, 2007.
31. Wai ES, Trevisan CH, Malfair Taylor SC, Mates D, Jackson JS, Olivotto IA. Health System Costs of Metastatic Breast Cancer. Breast Cancer Research and Treatment 2001;65:233-40.
32. Table 326-0002: Consumer Price Index (CPI), 2001 basket content. Health and Personal Care. Ottawa: Statistics Canada, 2007.
33. TreeAge Software. TreeAge Pro 2013. Williamstown, MA: TreeAge Software, Inc, 2013.
34. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press, 2005.
35. Laupacis A, Feeny D, Detsky AS, Tugwell PX. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. Canadian Medical Association Journal 1992;146:473-81.
36. Stout NK, Rosenberg MA, Trentham-Dietz A, Smith MA, Robinson SM, Fryback DG. Retrospective Costeffectiveness Analysis of Screening Mammography. Journal of the National Cancer Institute 2006;98:774-82.
37. Mandelblatt JS, Cronin KA, Bailey S, et al. Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms. Annals of Internal Medicine 2009;151:738-47.
38. Gunsoy NB, Garcia-Closas M, Moss SM. Estimating breast cancer mortality reduction and overdiagnosis due to screening for different strategies in the United Kingdom. Br J Cancer 2014;110:2412-9.
39. Coldman A, Phillips N. Incidence of breast cancer and estimates of overdiagnosis after the initiation of a populationbased mammography screening program. Canadian Medical Association Journal 2013;185:E492-E8.
40. Pisano ED, Gatsonis C, Hendrick E, et al. Diagnostic Performance of Digital versus Film Mammography for Breast-Cancer Screening. New England Journal of Medicine 2005;353:1773-83.
41. Tosteson ANA, Stout NK, Fryback DG, et al. Cost- Effectiveness of Digital Mammography Breast Cancer Screening. Annals of Internal Medicine 2008;148:1-10.
42. Michell MJ, Iqbal A, Wasan RK, et al. A comparison of the accuracy of film-screen mammography, full-field digital mammography, and digital breast tomosynthesis. Clinical Radiology 2012;67:976-81.
43. Saslow D. American cancer society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007;57:75-89.
44. Berg WA, Blume JD, Cormack JB, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA 2008;299:2151-63.
45. Hooley RJ, Greenberg KL, Stackhouse RM, Geisel JL, Butler RS, Philpotts LE. Screening US in Patients with Mammographically Dense Breasts: Initial Experience with Connecticut Public Act 09-41. Radiology 2012;265:59-69.
46. Yaffe M. Mammographic density. Measurement of mammographic density. Breast Cancer Research 2008;10:209.